Skip to main content
Full access
Letters to the Editor
Published Online: 1 September 2020

Early Detection and Preventive Treatment in Bipolar Disorder

To the Editor: In the October 2019 issue of the Journal, Lieberman et al. (1) wrote an excellent review article titled “Early Detection and Preventive Intervention in Schizophrenia: From Fantasy to Reality.” The authors cited three advances that highlighted the potential for disease-modifying treatment. These were the findings that the duration of untreated illness predicted outcome, that first-episode cases responded better than later ones, and that gray matter volume decreased with the illness. They cited 18 studies of intervention in high-risk patients beginning in 2002.
Parallel findings of the potential for disease-modifying treatments are available for bipolar disorder, but few intervention studies in individuals at high risk for bipolar and related disorders have ensued despite cogent rationales. In bipolar disorder, as in schizophrenia, the duration of untreated illness is related to poor outcome in adulthood (2); early treatment is better than later treatment, and gray matter volume is lost (3).
At the same time, progressively increasingly high-risk individuals can readily be identified on the basis of having a family history of bipolar disorder, psychosocial adversity in childhood, and an emergence of prodromal symptoms (4). A study of positive parental history of bipolar disorder alone revealed that 74% of offspring followed for 8 years developed a major psychiatric diagnosis, including (in decreasing percentages) anxiety disorder (40%), major depression, attention deficit hyperactivity disorder, disruptive behavior disorder, substance use disorder, subthreshold bipolarity (13.3%), and mania/hypomania (9.2%) (5). Each of these childhood illnesses deserves to be recognized and treated.
What was seen as a problem of nonspecificity and low risk of conversion to schizophrenia in those at high risk (1) could be used as a positive and an asset in studies of those at high risk for mood disorders. Many of the safest candidates for study of early intervention appear to have nonspecific therapeutic illness targets. These could include: phosphatidylcholine; vitamin D3 and other vitamin preparations; omega-3 fatty acids; N-acetylcysteine; acetyl-l-carnitine; minocycline; celecoxib; and more aggressive interventions with antidepressants, anticonvulsants, atypical antipsychotics, and lithium.
One could then study the success of a drug not only on the conversion rate to bipolarity of about 20% but also on the much higher 74% conversion rate to any major psychiatric illness. If one also included a history of childhood adversity and the presence of prodromal symptoms in the calculation, the risk of illness would even be higher and the rationale for intervention stronger (4). Family-focused therapy has already demonstrated success in those at high risk (6).
Studies in bipolar disorder are almost 2 decades behind those in schizophrenia (1); the need is great; the rationale is strong; and the potential interventions for study are even more plentiful. Thus, a new round of studies of early intervention in individuals at high risk for bipolar and multiple other psychiatric disorders should be given the highest priority so that, as Lieberman et al. (1) subtitled their article, we could also move “from fantasy to reality.”

References

1.
Lieberman JA, Small SA, Girgis RR: Early detection and preventive intervention in schizophrenia: from fantasy to reality. Am J Psychiatry 2019; 176:794–810
2.
Post RM, Leverich GS, Kupka RW, et al: Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood. J Clin Psychiatry 2010; 71:864–872
3.
Post RM, Fleming J, Kapczinski F: Neurobiological correlates of illness progression in the recurrent affective disorders. J Psychiatr Res 2012; 46:561–573
4.
Post RM, Chang K, Frye MA: Paradigm shift: preliminary clinical categorization of ultrahigh risk for childhood bipolar disorder to facilitate studies on prevention. J Clin Psychiatry 2013; 74:167–169
5.
Axelson D, Goldstein B, Goldstein T, et al: Diagnostic precursors to bipolar disorder in offspring of parents with bipolar disorder: a longitudinal study. Am J Psychiatry 2015; 172:638–646
6.
Miklowitz DJ, Schneck CD, Singh MK, et al: Early intervention for symptomatic youth at risk for bipolar disorder: a randomized trial of family-focused therapy. J Am Acad Child Adolesc Psychiatry 2013; 52:121–131

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 867
PubMed: 32880471

History

Accepted: 13 January 2020
Published online: 1 September 2020
Published in print: September 01, 2020

Keywords

  1. Child Onset Bipolar Disorder
  2. Depression
  3. Early Intervention
  4. Prevention

Authors

Details

Robert M. Post, M.D. [email protected]
Department of Psychiatry and Behavioral Sciences, George Washington University School of Medicine and Health Sciences, Washington, D.C., and Bipolar Collaborative Network, Bethesda, Md.

Notes

Send correspondence to Dr. Post ([email protected]).

Funding Information

Dr. Post has served on the speakers bureau for Janssen, Sunovion, and Takeda.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share